Supplementary Figure 1 from The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo

Authors :: Steven W. Elmore
Chris Tse
Joel D. Leverson
Deepak Sampath
Heather Maecker
Saul H. Rosenberg
Scott L. Ackler
Haichao Zhang
Stephen K. Tahir
Alexander R. Shoemaker
Yu Shen
Morey Smith
Xiaoyu Lin
Paul Nimmer
Michael J. Mitten
Bernard Liu
Xiaoli Huang
Vivek Abraham
Sha Jin
Jun Chen
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 78K

Full Text Access

Tools